Clindamycin: Potent Antibiotic for Serious Bacterial Infections
| Product dosage: 150mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.23 | $36.98 (0%) | 🛒 Add to cart |
| 60 | $1.05 | $73.96 $62.78 (15%) | 🛒 Add to cart |
| 90 | $1.00 | $110.94 $90.30 (19%) | 🛒 Add to cart |
| 120 | $0.97 | $147.92 $116.96 (21%) | 🛒 Add to cart |
| 180 | $0.94 | $221.88 $168.56 (24%) | 🛒 Add to cart |
| 270 | $0.92
Best per pill | $332.82 $248.54 (25%) | 🛒 Add to cart |
| Product dosage: 300mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.38 | $41.28 (0%) | 🛒 Add to cart |
| 60 | $1.19 | $82.56 $71.38 (14%) | 🛒 Add to cart |
| 90 | $1.13 | $123.84 $101.48 (18%) | 🛒 Add to cart |
| 120 | $1.09 | $165.12 $130.72 (21%) | 🛒 Add to cart |
| 180 | $1.07 | $247.68 $191.78 (23%) | 🛒 Add to cart |
| 270 | $1.04
Best per pill | $371.52 $280.36 (25%) | 🛒 Add to cart |
Synonyms | |||
Clindamycin is a lincosamide antibiotic prescribed for the treatment of a wide spectrum of serious anaerobic and aerobic gram-positive bacterial infections. It functions by inhibiting bacterial protein synthesis at the ribosomal level, making it a bacteriostatic agent, though it can exhibit bactericidal activity at higher concentrations depending on the organism and the drug’s concentration at the site of infection. Its efficacy against stubborn pathogens like Staphylococcus aureus (including some methicillin-resistant strains, MRSA), Streptococcus pneumoniae, and various anaerobic bacteria makes it a critical tool in both hospital and outpatient settings. This guide provides a comprehensive, expert-level overview of its proper use, mechanisms, and essential safety information.
Features
- Active Pharmaceutical Ingredient: Clindamycin (as clindamycin hydrochloride, clindamycin palmitate hydrochloride, or clindamycin phosphate).
- Drug Class: Lincosamide antibiotic.
- Mechanism of Action: Binds to the 50S subunit of the bacterial ribosome, suppressing protein synthesis.
- Spectrum of Activity: Effective against many gram-positive aerobes (e.g., staphylococci, streptococci) and anaerobic bacteria (e.g., Bacteroides, Clostridium, Fusobacterium, Peptostreptococcus).
- Available Formulations: Oral capsules (150 mg, 300 mg), oral solution, topical gel/lotion/solution (1%), vaginal cream (2%), and injectable formulations for intravenous or intramuscular administration.
- Bioavailability: Approximately 90% for oral administration, with no significant impact from food.
Benefits
- Targets Resistant Infections: Provides a reliable treatment option for skin and soft tissue infections caused by community-acquired MRSA.
- Excellent Tissue Penetration: Achieves high concentrations in bone, abscess cavities, and other poorly perfused tissues, making it ideal for deep-seated infections like osteomyelitis.
- Effective Against Anaerobes: A first-line choice for serious anaerobic infections below the diaphragm, including intra-abdominal abscesses, peritonitis, and pelvic inflammatory disease.
- Multiple Administration Routes: Availability in oral, topical, and parenteral forms allows for flexible treatment strategies, from severe systemic infections to localized acne.
- Synergistic Potential: Can be used in combination with other antibiotics, such as aminoglycosides, for broad-spectrum coverage in polymicrobial infections.
Common use
Clindamycin is indicated for infections caused by susceptible strains of microorganisms. Its common uses include:
- Serious Respiratory Tract Infections: Including empyema, anaerobic pneumonitis, and lung abscess.
- Skin and Soft Tissue Infections: Such as severe cellulitis, abscesses, and wound infections, particularly those suspected or confirmed to be caused by MRSA.
- Septicemia: Bloodstream infections caused by susceptible anaerobic bacteria.
- Intra-abdominal Infections: Including peritonitis and intra-abdominal abscesses often caused by gut flora like Bacteroides fragilis.
- Gynecological Infections: Including endometritis, nongonococcal tubo-ovarian abscess, and pelvic cellulitis.
- Bone and Joint Infections: Such as osteomyelitis caused by Staphylococcus species.
- Topical Use: For the treatment of acne vulgaris.
- Vaginal Use: For the treatment of bacterial vaginosis.
- Dental Infections: Used in odontogenic infections and prophylaxis against endocarditis in penicillin-allergic patients undergoing dental procedures.
Dosage and direction
Dosage is highly dependent on the severity of the infection, the causative organism, and the patient’s hepatic and renal function. The following are general guidelines; a healthcare provider’s precise instructions must always be followed.
- Adults (Oral): For serious infections, 150 to 300 mg every 6 hours. For more severe infections, 300 to 450 mg every 6 hours.
- Adults (Parenteral/IV/IM): For serious infections, 600 to 1200 mg per day, administered in 2, 3, or 4 equally divided doses. For life-threatening infections, doses of 1200 to 2700 mg per day may be given in 2, 3, or 4 equally divided doses.
- Pediatric Patients (Oral): 8 to 20 mg/kg/day divided into 3 or 4 equal doses.
- Pediatric Patients (Parenteral): 20 to 40 mg/kg/day divided into 3 or 4 equal doses, depending on the severity of the infection.
- Topical (Acne): Apply a thin layer to the affected area twice daily.
- Vaginal Cream: One full applicator (5 grams) intravaginally at bedtime for 7 consecutive days.
- Direction: Oral doses can be taken with or without food to minimize potential esophageal irritation. IV administration must be by slow infusion, never as a bolus, and is typically diluted in a solution like 0.9% Sodium Chloride or 5% Dextrose in Water.
Precautions
- Clostridium difficile-Associated Diarrhea (CDAD): Antibiotics, including clindamycin, disrupt normal colon flora and may permit overgrowth of C. difficile, which can cause severe, potentially fatal colitis. This can occur during or months after therapy. Diarrhea must be evaluated promptly.
- Hepatic and Renal Impairment: Use with caution in patients with severe hepatic dysfunction, as metabolism is primarily hepatic. Dose adjustment may not be necessary in renal impairment, but caution is still advised.
- Superinfection: Use may result in overgrowth of non-susceptible organisms, particularly fungi. Close monitoring for new infections is essential.
- Atopic Individuals: Use with caution in patients with a history of asthma, eczema, or other allergic conditions.
- Neuromuscular Blockade: Clindamycin has neuromuscular blocking properties and may potentiate the effect of other neuromuscular blocking agents; use with extreme caution in patients receiving such drugs.
Contraindications
Clindamycin is contraindicated in patients with:
- A known hypersensitivity to clindamycin, lincomycin, or any component of the formulation.
- A history of antibiotic-associated colitis, including CDAD.
Possible side effect
Side effects can range from common and mild to rare and severe.
- Common: Gastrointestinal disturbances are most frequent, including nausea, vomiting, epigastric pain, abdominal cramping, and diarrhea (which may be a precursor to CDAD).
- Dermatological: Skin rashes, urticaria (hives), and itching. Severe reactions like Stevens-Johnson Syndrome are rare.
- Hematological: Transient neutropenia (low white blood cell count), eosinophilia, and thrombocytopenia have been reported.
- Hepatic: Jaundice and liver function test abnormalities.
- Local Reactions: Pain, induration, and sterile abscess at the site of intramuscular injection; thrombophlebitis after intravenous administration.
- Topical/Vaginal: Localized irritation, burning, itching, dryness, peeling, or erythema at the application site.
Drug interaction
Clindamycin can interact with several other medications:
- Neuromuscular Blocking Agents (e.g., pancuronium, succinylcholine): May enhance neuromuscular blockade, leading to increased skeletal muscle relaxation and respiratory depression.
- Erythromycin and Chloramphenicol: These drugs are also inhibitors of protein synthesis and may antagonize the antibacterial effects of clindamycin; concomitant use is not recommended.
- Opioid Antidiarrheals (e.g., diphenoxylate/atropine, loperamide): May delay the elimination of C. difficile toxins from the colon and should be avoided in patients with diarrhea.
- Cytochrome P450 Substrates: In vitro data suggests clindamycin may inhibit CYP3A4 and CYP2C19, but the clinical significance of this is considered low.
Missed dose
- If a dose is missed, it should be taken as soon as it is remembered.
- However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed.
- Do not double the dose to make up for the missed one, as this increases the risk of side effects.
Overdose
- Symptoms of overdose would be an extension of the known side effects, primarily severe gastrointestinal distress (nausea, vomiting, diarrhea).
- There is no specific antidote for clindamycin overdose.
- Treatment is supportive and symptomatic. Gastric lavage may be considered if ingestion was recent. Hemodialysis or peritoneal dialysis is not effective in removing clindamycin from the blood.
- Medical attention should be sought immediately in case of suspected overdose.
Storage
- Store all formulations at room temperature, between 20°C to 25°C (68°F to 77°F), in a tight, light-resistant container.
- Keep away from excess moisture and heat.
- Do not freeze the oral solution. The reconstituted oral solution is stable for 2 weeks at room temperature.
- Keep all medications out of the reach of children and pets.
Disclaimer
This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
- Clinical Efficacy (5/5): “As an infectious disease specialist, clindamycin remains a cornerstone of our arsenal for anaerobic and MRSA infections. Its tissue penetration is superior to many alternatives.”
- Safety Profile (3/5): “Extremely effective, but the specter of C. diff colitis is always present. Requires vigilant patient education about reporting any diarrhea immediately. The benefit often outweighs the risk in appropriate clinical scenarios.”
- Patient Experience (4/5): “Cleared a severe facial abscess that wasn’t responding to other antibiotics. The GI upset was significant but manageable with food. Worth the discomfort for the result.”
- Topical Formulation (4/5): “A dermatology staple for inflammatory acne. Works well as part of a combination regimen. Can cause dryness and peeling, which requires careful moisturizer management.”